GlaxoSmithKline, AstraZeneca PLC and other Pharmaceutical Leaders Reduce R&D Time and Costs Using Aspen Technology’s Software

BURLINGTON, Mass.--(BUSINESS WIRE)--Aspen Technology, Inc. (NASDAQ: AZPN), a leading provider of software and services to the process industries, today announced that GlaxoSmithKline, AstraZeneca and other pharmaceutical industry leaders are reducing their research and development time and costs using newly patented technology that is part of AspenTech’s aspenONE Process Development for Pharmaceuticals software.

MORE ON THIS TOPIC